1Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to P53 at lp36, a region frequently deleted in neuroblastoma and other human cancer[J]. Cell, 1997 ,90(4) :809 - 819.
2Chi SW, Ayed A, Arrowsmith CH. Solution structure of a conserved Cterminal domain of P73 with structural homology to the SAM domain[J].EMBO J, 1999,18(16) :4438 - 4445.
3Yang A, Kaghad M, Wang Y, et al. P63,a P53 homolog at 3q27-29,encodes multiple products with transactivating death-inducing and dominant negative activities[J]. Mol Cell,1998,2(3):305 - 316.
4Nakagawa T, Takahashi M, Ozaki T, et al. Autoinhibitory regulation of P63 by △NP73 to modulate cell survival and death through a P73-specific target element within the△NP73 promoter[J]. Mol Cell Biol,2002,22(8):2575 - 2585.
5Kartasheva N, Contente A, Lenz-Stoppler C, et al. P53 induces the expression P73△N, establishing an autoregulatory feedback loop[J].Oncogene, 2002,21(31): 4715-4727.
6Haupt Y, Maya R, Kazaz A, Oren M. MDM2 promotes the rapid degradation of P53[J] .Nature, 1997,387(6630):296 - 299.
7Minty A, Dumont X, Kaghad M, et al. Cvalent modification of P73a by SUMO-1.Two-hybrid screening with P73 identifies novel SUMO-1 interacting proteins and a SUMO-1 interaction motif[J].J Boil Chem,2000,275 (46): 36316 - 36323.
8Calabro V, Mansueto G, Parisi T, et al. The human MDM2 oncoprotein increases the transcriptional activity and the protein level of the P53-homologue P63[J] .J Biol Chem,2001,277(4):2674 - 2681.
9Stiewe T, Theseling CC, Putzer BM. Transactivation-deficient Delta TaP73 inhibits P53 by direct competition for DNA binding:implications for tumorigenesis[J].J Biol Chem,2002,277(16):14177-14185.
10Grob TJ, Fey MF, Tobler A. The two faces of P73[J]. Cell Death Diffeer, 2002,9(3):237 - 245.
